Interview - Märkische Allgemeine (MAZ)

Last weekend, our project Kykeon Biotech was featured in the newspaper for the first time. Our entire team is very pleased that the Märkische Allgemeine (MAZ) presented comprehensive reports on the startup ecosystem in the Berlin-Brandenburg region. In this context, Kykeon Biotech had the opportunity to present its technology for the cell-free production of proteins. Furthermore, we were able to talk about our cooperation with the Technical University of Applied Sciences Wildau and present regional funding opportunities. Thanks again to the entire editorial team and the author Gerald Dietz for this great opportunity.


It is not only in relation to the pandemic that the founders of the startup Kykeon Biotech see a market and social benefit to their developments. Their technology for the more sustainable production of artificial proteins could also be used for the manufacture of drugs such as insulin. Currently, the startup is paying more attention to the fact that the recombinant proteins can improve common diagnostic tests in economical and ecological ways. Instead of creating cell cultures, the team uses biomasses found in nature. The team is supported by the Startup Center of the Technical University of Applied Sciences in Wildau.

Kykeon Biotech at MAZ 2

key message of the interview

"Collaborations are indispensable to realize Kykeon Biotech's goals. The collaboration with TH Wildau and the Department of Molecular Biotechnology and Functional Genomics is enormously important."

Would you like to learn more? Book your personal appointment with KYKEON Biotech here: